Supply Chain

pharmaceutical manufacturing
Supply Chain
 // November 06, 2024

Global manufacturing capacity for active pharmaceutical ingredients remains concentra...

The globalization of the medicines supply chain has helped to increase access to quality medicines at a lower cost. At the same time, the supply chain has grown longer, more complex, and fragmented, leading to a lack of visibility and increase in the risk to its resilience. In many instances, globalization has also led to the concentration of production in a few geographies. Insights from USP’s Medicine Supply Map demonstrate that geographic concentration of pharmaceutical manufacturing anywhere in the world – including within the United States – increases the risk for drug shortages.
E
Erkan Duman, PhD
row of pills
Supply Chain
 // October 13, 2021

Standards Enable a Strong Medicines Supply Chain

Standards Enable a Strong Medicines Supply Chain

Standards play an important role in the global medicines supply chain, helping governments and manufacturers increase the availability of safe, quality medicines, as well as building patient and health provider trust. In fact, quality standards are a big reason why we in the U.S. can get a prescription filled at our neighborhood pharmacy and trust that the medicine we receive will be safe and work as it should.

pharmaceutical manufacturing
Supply Chain
 // November 06, 2024

Global manufacturing capacity for active pharmaceutical ingredients remains concentra...

The globalization of the medicines supply chain has helped to increase access to quality medicines at a lower cost. At the same time, the supply chain has grown longer, more complex, and fragmented, leading to a lack of visibility and increase in the risk to its resilience. In many instances, globalization has also led to the concentration of production in a few geographies. Insights from USP’s Medicine Supply Map demonstrate that geographic concentration of pharmaceutical manufacturing anywhere in the world – including within the United States – increases the risk for drug shortages.
E
Erkan Duman, PhD
Medicines Supply Chain
Supply Chain
 // November 27, 2023

Building a More Resilient Medicines Supply Chain

Building a More Resilient Medicines Supply Chain

In this Q&A with the Duke-Margolis Drug Supply Chain Resilience and Advanced Manufacturing Consortium, US Pharmacopeia (USP) policy expert Amy B. Cadwallader highlights the importance of multi-disciplinary, cross-functional coordination to strengthen the medicine supply chain and global public health resilience in the face of ongoing threats, like persistent drug shortages. This Q&A was first published in the Consortium's eNewsletter and is re-printed with the permission of the Duke-Margolis Center for Health Policy.

Amy Cadwallader
Amy Cadwallader